Taperloc Versus Taplerloc Microplasty
Clinical Evaluation of Taperloc Total Hip System With Two Different Stem Lengths
1 other identifier
interventional
60
1 country
1
Brief Summary
This evaluation is conducted to evaluate the safety and performance of two different stem lengths of the Taperloc Total Hip System. Per implant bone loss and migration of the stem are compared between the two groups with Dual-energy X-ray absorptiometry (DEXA) and radiostereomektric analysis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2008
CompletedFirst Posted
Study publicly available on registry
September 22, 2008
CompletedStudy Start
First participant enrolled
October 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedMarch 14, 2016
March 1, 2016
3 years
September 19, 2008
March 11, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bone remodelling, i e change in bone mineral density around the stem, as measured with dual energy x-ray absorptiometry (DEXA) [ Time Frame:
bone mineral density (BMD) measured postoperatively at 2 years
Secondary Outcomes (1)
Migration of stem components in six degrees of freedom and maximum total point motion measured with radiostereometric analysis
2 years
Other Outcomes (2)
Clinical outcome measures with Harris Hip Score comparing patients receiving different stems.
3, 6, 12 and 24 months
Clinical outcome measures with Womac Score comparing patients receiving different stems.
3, 6, 12 and 24 months
Study Arms (2)
Taperloc Microplasty
EXPERIMENTALPatients with primary osteoarthritis with Taperloc microplasty non inferiority
Taperloc Standard
ACTIVE COMPARATORPatients with primary osteoarthritis Taperloc standard
Interventions
Eligibility Criteria
You may qualify if:
- Patients with primary osteoarthritis of the hip scheduled for THA.
- Suitable anatomy for both stems
- Willingness and ability to follow study-protocol
You may not qualify if:
- Malignancy or metastatic bone disease.
- Any other disease severely affecting bone and mineral metabolism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ingemar Ivarssonlead
- Biomet U.K. Ltd.collaborator
Study Sites (1)
University hospital of Linkoping
Linköping, 581 85, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ingemar IVARSSON, PhD
University hospital of Linkoping
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 19, 2008
First Posted
September 22, 2008
Study Start
October 1, 2011
Primary Completion
October 1, 2014
Study Completion
June 1, 2015
Last Updated
March 14, 2016
Record last verified: 2016-03
Data Sharing
- IPD Sharing
- Will share